FCM
JAZZ icon

Frontier Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Frontier Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.8M Buy
517,284
+335,083
+184% +$58.6M 1.01% 17
2025
Q4 		$31M Buy
182,201
+143,692
+373% +$22M 0.33% 110
2025
Q3 		$5.08M Sell
38,509
-1,157
-3% -$139K 0.05% 274
2025
Q2 		$4.21M Sell
39,666
-120
-0.3% -$13K 0.04% 277
2025
Q1 		$4.94M Buy
39,786
+4,784
+14% +$624K 0.05% 255
2024
Q4 		$4.31M Buy
35,002
+11,027
+46% +$1.3M 0.04% 260
2024
Q3 		$2.67M Sell
23,975
-441
-2% -$48.3K 0.03% 262
2024
Q2 		$2.61M Sell
24,416
-8,830
-27% -$971K 0.03% 265
2024
Q1 		$4M Sell
33,246
-26,591
-44% -$3.26M 0.04% 254
2023
Q4 		$7.36M Buy
59,837
+1,370
+2% +$171K 0.07% 217
2023
Q3 		$7.57M Buy
58,467
+18,070
+45% +$2.41M 0.08% 206
2023
Q2 		$5.01M Sell
40,397
-19,146
-32% -$2.58M 0.05% 232
2023
Q1 		$8.71M Sell
59,543
-170,583
-74% -$25.2M 0.09% 204
2022
Q4 		$36.7M Buy
230,126
+69,305
+43% +$10.2M 0.4% 100
2022
Q3 		$21.4M Buy
160,821
+83,286
+107% +$12.7M 0.25% 138
2022
Q2 		$12.1M Buy
+77,535
New +$11.9M 0.14% 193

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Frontier Capital Management's JAZZ Position: Q1 2026 in Review

Frontier Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 184% in Q1 2026, buying an estimated $58.6M and bringing the position to 517,284 shares worth $97.8M. The position accounts for 1.01% of the portfolio, ranked #17.

Frontier Capital Management first reported a position in JAZZ in Q2 2022 and has held it in 16 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Frontier Capital Management held 517,284 shares of Jazz Pharmaceuticals worth $97.8M as of Q1 2026.
  • Frontier Capital Management bought 335,083 Jazz Pharmaceuticals shares in Q1 2026, an estimated $58.6M.
  • Jazz Pharmaceuticals made up 1.01% of Frontier Capital Management's portfolio in Q1 2026, its #17 holding.
  • Frontier Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.